Improving the efficacy of cancer immunotherapy by host-defence caerin 1.1 and 1.9 peptides
Cancer remains a major global health challenge. Immunotherapy has revolutionized the management of cancer, yet only a limited number of patients respond to such treatments. This is largely attributed to the immunosuppressive tumor microenvironment, which diminishes the effectiveness of immunotherapy...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2024-12-01
|
| coleção: | Human Vaccines & Immunotherapeutics |
| Assuntos: | |
| Acesso em linha: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2385654 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
